Lonza has made a non-binding offer to acquire Patheon. Lonza has offered $3.55/share valuing Patheon at $460m. Lonza ceo Stefan Borgas said Lonza was looking to expand its offering to cover more of the manufacturing supply chain and Patheon's finished dosage manufacturing capability would fill a gap. He added that Patheon was one of several opportunities in the area that lonza had been following over the last couple of years.
Reuters
Thursday, 27 August 2009
Lonza makes offer for Patheon
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment